Pregnancy · Emergency Treatments
Magnesium Sulphate — Eclampsia & Neuroprotection
IV magnesium sulphate in pregnancy: seizure prevention in severe preeclampsia/eclampsia (Magpie trial showed 50% reduction); fetal neuroprotection <32 weeks (30% reduction in cerebral palsy). What it feels like, side effects, monitoring. NICE NG25 / Magpie 2002.
Last reviewed 2 June 2026
Neuroprotection or eclampsia regimen
Indication
Duration: Until delivery, or up to 24 hours (re-bolus protocols vary if delivery delayed).
Toxicity monitoring
- Deep tendon reflexes — loss correlates with Mg > 10 mEq/L; STOP infusion if absent.
- Respiratory rate < 12/min — respiratory depression risk; STOP and call team.
- Urine output < 30 mL/h — reduce or stop; Mg is renally cleared.
- Reversal: Calcium gluconate 1 g IV (10 mL of 10 % solution) over 10 min.
Why magnesium sulphate?
Two main indications in pregnancy:
- Seizure prevention / treatment in severe pre-eclampsia / eclampsia.
- Fetal neuroprotection before preterm delivery (<32 weeks usually).
Blocks calcium channels, stabilises nerve cells → reduces seizure risk + protects developing fetal brain. Widely used; one of safest emergency obstetric drugs.
How is it given?
- IV infusion through cannula.
- Loading dose: 4g over 5-15 min (Pritchard) OR 6g (Zuspan).
- Maintenance: 1-2 g/hour for 24 hours.
- Hospital-only drug; careful monitoring.
- Antidote (calcium gluconate) ready in case of toxicity.
What does it feel like?
Loading dose: warmth all over body (like hot flush); can be intense; sometimes nausea, headache, brief flushing.
Afterwards: less dramatic; mild warmth; slight muscle weakness; sometimes drowsy / “spaced out”.
Not painful or cramping. Most women describe as “unusual but tolerable”.
Safe for baby?
Yes. Crosses placenta but no harm at therapeutic doses. Protective for fetal brain at preterm.
Neonatal: transient muscle weakness in newborn if infusion close to delivery — usually resolves quickly.
For neuroprotection
Given before delivery <32 weeks to reduce cerebral palsy risk by ~30%.
NICE NG25:
- Planned or anticipated preterm delivery within 24h.
- Gestation 24-32 weeks (some 23-34).
- 4g loading + 1g/hr maintenance for 24 hours OR until delivery.
- Restart if delivery delayed >7 days + still preterm risk.
For eclampsia / severe PE
Magpie Trial (Lancet 2002, 10,000 women): ~50% reduction in eclampsia. Mortality reduced.
Indications:
- Severe PE (BP ≥160/110 or severe symptoms / organ involvement).
- Existing eclamptic seizure.
- Threatening seizure (severe headache, visual changes).
4g loading + 1g/hr for 24h after delivery.
Side effects
- Flushing / warmth (most common, loading dose).
- Nausea / vomiting (~10%).
- Headache.
- Weakness.
- Drowsiness.
- Reduced reflexes (monitored).
- Decreased urine output (monitored).
- Rare: respiratory depression / muscle weakness affecting breathing (with toxicity).
Toxicity prevention
Monitoring every 1-2 hours during infusion:
- Respiratory rate (≥12/min).
- Urine output (≥30 mL/hour).
- Deep tendon reflexes (knee-jerk — lost reflexes early sign).
- Magnesium levels (therapeutic 1.7-3.5 mmol/L).
Antidote: 10% calcium gluconate 10 mL IV slowly. Reverses toxicity.
Breastfeeding
Safe. Minimal transfer to breast milk. Initial delay only if you’re too sedated. Baby may be slightly sleepy initially; encourage feeding when alert.
Eclamptic seizure — what happens
~1-2 per 1000 pregnancies. Emergency. Convulsions, loss of consciousness, sometimes prolonged.
- Protect from injury (don’t restrain; clear airway after).
- Magnesium sulphate loading dose IV.
- Oxygen.
- Delivery planning.
Recovery: usually no lasting damage with prompt treatment. Memory of seizure usually absent. PTSD common — counselling important.
Different scenarios — magnesium sulphate
Scenario 1: Severe PE 32 weeks, BP 165/110
Magnesium sulphate IV loading + maintenance. BP control. Steroids. Likely delivery 24-48h.
Scenario 2: Eclamptic seizure 28 weeks
Emergency magnesium loading. Oxygen. Stabilise. Then plan delivery. Continue magnesium 24h post-delivery.
Scenario 3: 28-week preterm labour despite tocolysis
Magnesium for neuroprotection started as delivery anticipated. Steroids if not given. NICU prep.
Scenario 4: Postpartum day 3, BP rising, severe headache
Postpartum eclampsia risk. Magnesium consideration if BP unstable + symptoms. BP control. Monitoring.
Scenario 5: Previous eclampsia, planning next pregnancy
Preconception consult. Aspirin from <16 wk. Intensive monitoring. Magnesium ready if PE develops again.
Care guidance — magnesium sulphate
- IV infusion; hospital only.
- Warmth during loading; usually settles.
- Monitoring: BP, HR, RR, urine, reflexes.
- Antidote ready (calcium gluconate).
- Neuroprotection <32 weeks reduces CP by 30%.
- Eclampsia treatment — first-line.
- Severe PE seizure prevention — halves risk.
- Safe for baby; minor transient newborn effects.
- Safe in breastfeeding.
- Continue 24h postpartum for PE/eclampsia.
- Mental health support if eclamptic seizure (trauma).
Sources
- NICE NG25. Preterm labour and birth.
- NICE NG133. Hypertension in pregnancy.
- Altman D, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial. Lancet 2002.
- Doyle LW, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009.
- RCOG Green-top Guideline 10A. Severe pre-eclampsia / eclampsia.
Recommended for this calculator